InvestorsHub Logo
Followers 35
Posts 791
Boards Moderated 0
Alias Born 09/16/2020

Re: hyperopia post# 453463

Wednesday, 03/23/2022 12:52:59 AM

Wednesday, March 23, 2022 12:52:59 AM

Post# of 701138
hyperopia: I appreciate the context you have given regarding BATON. I am searching for the reason why this "new" manufacturing method was patented now without any trials ongoing. I have come up with 3 possible reasons:

1) Other organizations are close to patenting something close, and they want to own the IP.

2) Part of the conditions for potentially selling NWBO dictate securing patents surrounding and including the new processes that can be used in conjunction with DCVax.

3) This is signaling intent to pursue a broader treatment approach ahead for the solid cancer space.

My main concern with having a patent w/o associated trials is of course by the time a future trial is complete there will not be much patent life left unless improvements can be made to extend the protection.

Your comment that they could just license the technology to generate cash could be the reason as well.

I am obviously missing a concept here since this move doesn't make sense to me regarding the path outlined for commercializing DCVax-L.

Peace.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News